AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
MOLNUPIRAVIR
22 registrations across 7 African markets— 21 active
Markets with MOLNUPIRAVIR
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| MOLNAFLU CAPSULES | 🇷🇼Rwanda | AUROBINDO PHARMA LIMITED | active | Jul 2030 |
| MOVFOR Capsules | 🇷🇼Rwanda | Hetero Labs Limited (Unit -V) | active | Aug 2029 |
| MOLNARZ | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | active | Jul 2028 |
| MOLNUPIRAVIR 200 DRL | 🇿🇦South Africa | Dr ReddyÆs Laboratories (Pty) Ltd | active | Jul 2028 |
| LAGEVRIO | 🇿🇦South Africa | MSD (Pty) Ltd | active | Dec 2027 |
| MOLUMUS 200 | 🇿🇦South Africa | Bliss Pharmaceuticals (Pty) Ltd | active | Jul 2025 |
| MOVFOR 200MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Mar 2024 |
| MOVFOR gélule / 200 mg | 🇸🇳Senegal | HETERO LABS LIMITED | active | — |
| Molnupiravir | 🌍WW | Divi’s Laboratories Limited | active | — |
| Molnupiravir | 🌍WW | Optimus Drugs Pvt Ltd | active | — |
| MOLNUPIRAVIR ORAL SOLID
RETARD OTHER
CAPSULES | 🇺🇬Uganda | M/S HETERO LABS LIMITED | active | — |
| MOLNUPIRAVIR ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | EMCURE PHARMACEUTICA LS LTD - | active | — |
| Molnupiravir | 🌍WW | Aurore Life Sciences Private Limited | active | — |
| Molnupiravir | 🌍WW | Aurobindo Pharma Ltd | active | — |
| Molnupiravir | 🌍WW | Matrix Pharmacorp Private Limited | active | — |
| MOLNUPIRAVIR ORAL SOLID RETARD
OTHER CAPSULES | 🇺🇬Uganda | M/S HETERO LABS LIMITED | active | — |
| MOLNUPIRAVIR ORAL SOLID RETARD
OTHER CAPSULES | 🇺🇬Uganda | M/S HETERO LABS LIMITED | active | — |
| MOLNUPIRAVIR ORAL SOLID
RETARD OTHER
CAPSULES | 🇺🇬Uganda | M/S HETERO LABS LIMITED | active | — |
| MOLNUPIRAVIR ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | EMCURE PHARMACEUTICA LS LTD - | active | — |
| MOVFOR gélule / 200 mg | 🇸🇳Senegal | HETERO LABS LIMITED | active | — |
| MOVFOR Capsules | 🇹🇿Tanzania | Hetero Labs Limited | active | — |
| Molnupiravir | 🌍WW | Shanghai Desano Chemical Pharmaceutical Co Ltd | active | — |
MOLNUPIRAVIR in Africa — Regulatory Overview
MOLNUPIRAVIR is registered across 7 African markets with 22 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including WW, Uganda, South Africa, Senegal and 3 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 22 registrations, 21 (95%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.